Related Experiment Videos
Human lymphocyte membrane proteins treated with neuraminidase
Biochimica Et Biophysica Acta
|December 22, 1982
Summary
Neuraminidase treatment affects lymphocyte membrane proteins. A 45,000 MW protein sensitive to this enzyme was identified, alongside a 60,000 MW soluble protein.
Area of Science:
- Cellular Biology
- Biochemistry
- Immunology
Background:
- Lymphocyte surface proteins play crucial roles in cellular function and immune responses.
- Understanding protein modifications, such as those induced by enzymes like neuraminidase, is vital for deciphering cell signaling pathways.
Purpose of the Study:
- To investigate the impact of neuraminidase treatment on human peripheral blood lymphocyte membrane proteins.
- To identify specific proteins affected by neuraminidase and characterize their properties.
Main Methods:
- Surface iodination of human peripheral blood lymphocytes.
- Treatment with neuraminidase from Vibrio cholerae on both intact cells and isolated membrane fractions.
- Cell lysis using non-ionic detergent.
- Two-dimensional gel electrophoresis for protein analysis.
Main Results:
- A 45,000 MW surface-labeled protein, associated with the detergent-resistant matrix and enriched in isolated membranes, showed high sensitivity to neuraminidase.
- Neuraminidase treatment of intact cells released a prominent 60,000 MW labeled protein into the soluble fraction.
- An analogous 60,000 MW protein was observed when isolated membrane fractions were treated with neuraminidase.
Conclusions:
- Neuraminidase significantly alters the structure and localization of specific lymphocyte membrane proteins.
- The identified 45,000 MW protein is a key target for neuraminidase activity within the lymphocyte membrane.
- The release of the 60,000 MW protein suggests enzymatic cleavage and subsequent solubilization, impacting cellular signaling or structure.